2007
DOI: 10.1002/14651858.cd002755.pub2
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Intravenous magnesium for acute myocardial infarction

Search citation statements

Order By: Relevance

Paper Sections

Select...
60
8
2
1

Citation Types

0
35
0
0

Year Published

Range
1988
1988
2025
2025

Publication Types

Select...
60
6
3

Relationship

1
68

Authors

Journals

citations

Cited by 69 publications

(35 citation statements)
references

References 55 publications

0
35
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Although cohort studies can be indicative of a positive effect of magnesium on human health, randomized controlled clinical (interventional) trials are required to prove first and foremost causality, and whether correcting serum magnesium towards a specific target value is therapeutic or preventive. A systematic review and meta-analysis of the effect of intravenous magnesium supplementation on myocardial infarction demonstrates that magnesium is not beneficial [14]. Similar outcomes were shown for stroke, as intravenous Mg 2+ supplementation did not improve mortality in patients with stroke [15].…”
Section: Randomized Clinical Trials
mentioning
confidence: 85%